Circular hybrid membrane process treating high-salinity ammonium-rich pharmaceutical wastewater

Ammonia-rich saline wastewater is a common byproduct of the pharmaceutical industry. Hollow fiber membrane contactors (HFMCs) show potential for NH3 3 recovery, enabling valuable product recycling. Our previous work indicated that excessive NaOH usage and increased salinity of the treated effluent are major setbacks when employing HFMCs for NH3 3 recovery from pharma wastewater. Therefore, finding alternative approaches to reduce chemical use and salinity is vital. This study demonstrates the integration of bipolar membrane electrodialysis (BMED) with HFMC for NH3 3 recovery, chemical recycling, and salinity reduction. This novel, highly circular concept was tested using real pharmaceutical wastewater. We varied the volume ratios between compartments to assess the BMED flexibility in attaining different treatment goals. BMED achieved over 90% salinity reduction and produced concentrated base and acid in all volume ratios tested, saving 70% of the NaOH required for pH increase before the HFMC step. The HFMC achieved over 98% NH3 3 recovery in two sets of five consecutive cycles, using either a BMED-generated base or NaOH. A preliminary economic analysis revealed a 47% reduction and 86% increase in expenses on chemicals and energy, respectively, compared to HFMC without BMED. Nevertheless, since the largest operating expense was the purchase of chemicals, integrating the BMED step reduced the overall operating expenses of the treatment by 33% (from $3.76 to $2.54 per kg N). The treated effluent's quality allows discharge to conventional wastewater treatment plants, resulting in economic and environmental benefits. This work highlights the importance of innovative separation processes in advancing toward cleaner drug manufacturing.